Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia - Seite 3

About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 136,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

References
[1] World Health Organization. World Health Day - 7 April 2014. http://www.who.int/campaigns/world-health-day/2014/event/en/ [last accessed February 2014]
[2] Malaria No More. Zambia. https://secure.malarianomore.org/po1#/pages/zambia [last accessed February 2014]
[3] Malaria No More. Power of One. https://secure.malarianomore.org/po1#/pages/about-power-of-one [last accessed February 2014]

# # #

Novartis Media Relations

Central media line : [phone]
Eric Althoff Novartis Global Media Relations [phone] (direct) [phone] (mobile) [e-mail]	Nadine Schecker Novartis Malaria Initiative Communications [phone] (direct) [phone] (mobile) [e-mail]

e-mail: [e-mail]

For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact: [e-mail].

Novartis Investor Relations

Central phone:	[phone]
Samir Shah	[phone]	North America:
Pierre-Michel Bringer	[phone]	Stephen Rubino	[phone]
Thomas Hungerbuehler	[phone]	Susan Donofrio	[phone]
Isabella Zinck	[phone]
e-mail: [e-mail]		e-mail: [e-mail]

Media release (PDF)

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novartis International AG via Globenewswire

HUG#1774786

--- End of Message ---

Novartis International AG
P.O. Box Basel Switzerland

WKN: 904278;ISIN: CH0012005267;